Table 2 Health care utilization among IPF patients during the 12-month baseline period
IPF Cohort (N= 4,716) | IPF Diagnostic Testing Subgroup (N= 2,518) | |||||
|---|---|---|---|---|---|---|
N | % | N | % | |||
No Medication within 12 Months of Cohort Entry | 570 | 12.1 | 298 | 11.8 | ||
One Medication within 12 Months of Cohort Entry | 136 | 2.9 | 59 | 2.3 | ||
Two Medications within 12 Months of Cohort Entry | 100 | 2.1 | 46 | 1.8 | ||
Three or More Medications within 12 Months of Cohort Entry | 3,910 | 82.9 | 2,115 | 84.0 | ||
Any Hospitalization within 12 Months of Cohort Entry (yes/no) | 2,396 | 50.8 | 1,401 | 55.6 | ||
Critical Care Evaluation and Management | 722 | 15.3 | 447 | 17.8 | ||
Mean (SD) | Median | IQR | Mean (SD) | Median | IQR | |
Number of Physician Visitsa | 14.8 (10.8) | 12.0 | 8.0 - 19.0 | 16.2 (11.6) | 14.0 | 9.0 - 21.0 |
Number of Emergency Department Visitsa | 1.4 (2.2) | 1.0 | 0.0 - 2.0 | 1.5 (2.4) | 1.0 | 0.0 - 2.0 |
Number of Inpatient Stays | 0.9 (1.2) | 1.0 | 0.0 - 1.0 | 1.0 (1.3) | 1.0 | 0.0 - 1.0 |
Number of Inpatient Days | 7.2 (18.0) | 1.0 | 0.0 - 6.0 | 8.4 (19.3) | 1.0 | 0.0 - 8.0 |
Number of 3-Digit Diagnosis Codes | 31.6 (14.7) | 29.0 | 21.0 - 40.0 | 34.4 (14.9) | 32.0 | 23.0 - 43.0 |
Number of Surgical Proceduresa | 7.6 (7.2) | 6.0 | 3.0 - 10.0 | 8.4 (7.9) | 6.0 | 3.0 - 11.0 |
Number of Anesthesia Proceduresa | 0.5 (0.9) | 0.0 | 0.0 - 1.0 | 0.5 (0.9) | 0.0 | 0.0 - 1.0 |
Number of Unique Drugs Dispensed | 10.3 (7.4) | 10.0 | 5.0 - 15.0 | 10.8 (7.7) | 10.0 | 5.0 - 16.0 |
Medical Costs ($) | 6,033.9 (9,319.3) | 3,932.7 | 2,156.7 - 6,986.0 | 6,983.1 (9,791.5) | 4,479.6 | 2,684.1 - 7,864.9 |
Facility Costs ($) | 12,474.9 (22,355.4) | 4,845.6 | 864.9 - 15,263.1 | 15,086.9 (26,551.3) | 6,430.2 | 1,424.9 - 18,539.2 |
Pharmacy Costs ($) | 2,675.3 (5,854.3) | 1,350.8 | 326.7 - 3,186.2 | 2,787.4 (5,989.5) | 1,463.7 | 355.3 - 3,238.8 |
Total Costs ($) | 21,184.2 (28,913.5) | 11,865.2 | 5,465.4 - 25,713.4 | 24,857.5 (33,600.8) | 13,798.3 | 6,739.4 - 30,886.0 |